Katherine Bishop

Katherine Bishop

Director/Board Member at
DTx Pharma, Inc.
60 year
Health Technology
Consumer Services
Technology Services

Profile

Katherine M.
Bishop
is currently the Director at DTx Pharma, Inc. since 2022 and the SVP, Head-Rare Disease & External Innovation at ACADIA Pharmaceuticals, Inc. since 2021.
Previously, she worked as the Director-Preclinical Research & Development at Ceregene, Inc. from 2001 to 2009, Vice President-Clinical Development at Ionis Pharmaceuticals, Inc. from 2009 to 2015, Chief Scientific Officer at Tioga Pharmaceuticals, Inc. in 2015, Chief Scientific Officer at Otonomy, Inc. from 2017 to 2019, and Chief Scientific Officer at Locanabio, Inc. from 2019 to 2020.
Dr. Bishop holds a doctorate degree from the University of Alberta, and undergraduate degrees from the University of British Columbia and Simon Fraser University.

Katherine Bishop active positions

CompaniesPositionStart
Director/Board Member 2022-05-01

Former positions of Katherine Bishop

CompaniesPositionEnd
ACADIA PHARMACEUTICALS INC. Chief Tech/Sci/R&D Officer -
Chief Tech/Sci/R&D Officer 2020-11-30
OTONOMY Chief Tech/Sci/R&D Officer 2019-06-30
Chief Tech/Sci/R&D Officer 2016-10-31
IONIS PHARMACEUTICALS, INC. Corporate Officer/Principal 2015-03-31
See the detail of Katherine Bishop's experience

Training of Katherine Bishop

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

80

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Technology Services

  1. Stock Market
  2. Insiders
  3. Katherine Bishop